1. Home
  2. BCAB vs CURI Comparison

BCAB vs CURI Comparison

Compare BCAB & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • CURI
  • Stock Information
  • Founded
  • BCAB 2007
  • CURI 2015
  • Country
  • BCAB United States
  • CURI United States
  • Employees
  • BCAB N/A
  • CURI N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • CURI Movies/Entertainment
  • Sector
  • BCAB Health Care
  • CURI Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • CURI Nasdaq
  • Market Cap
  • BCAB 101.0M
  • CURI 88.5M
  • IPO Year
  • BCAB 2020
  • CURI N/A
  • Fundamental
  • Price
  • BCAB $1.57
  • CURI $1.81
  • Analyst Decision
  • BCAB Buy
  • CURI Strong Buy
  • Analyst Count
  • BCAB 2
  • CURI 1
  • Target Price
  • BCAB $5.00
  • CURI $3.00
  • AVG Volume (30 Days)
  • BCAB 1.2M
  • CURI 284.6K
  • Earning Date
  • BCAB 11-07-2024
  • CURI 11-06-2024
  • Dividend Yield
  • BCAB N/A
  • CURI 5.53%
  • EPS Growth
  • BCAB N/A
  • CURI N/A
  • EPS
  • BCAB N/A
  • CURI N/A
  • Revenue
  • BCAB $11,000,000.00
  • CURI $51,775,000.00
  • Revenue This Year
  • BCAB N/A
  • CURI N/A
  • Revenue Next Year
  • BCAB N/A
  • CURI $9.14
  • P/E Ratio
  • BCAB N/A
  • CURI N/A
  • Revenue Growth
  • BCAB N/A
  • CURI N/A
  • 52 Week Low
  • BCAB $1.14
  • CURI $0.45
  • 52 Week High
  • BCAB $4.02
  • CURI $3.00
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 40.91
  • CURI 45.71
  • Support Level
  • BCAB $1.33
  • CURI $1.54
  • Resistance Level
  • BCAB $2.53
  • CURI $1.67
  • Average True Range (ATR)
  • BCAB 0.26
  • CURI 0.19
  • MACD
  • BCAB -0.07
  • CURI -0.04
  • Stochastic Oscillator
  • BCAB 20.08
  • CURI 25.51

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About CURI CuriosityStream Inc.

CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions, and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.

Share on Social Networks: